Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced the launch of a novel scientific search engine designed to give researchers easier access to peer-reviewed articles and abstract information on the Company’s website, sigma-aldrich.com. The new search engine allows scientists to immediately read the full text of millions of peer-reviewed papers without extra clicks or logins, discover applications for specific Sigma-Aldrich products in peer-reviewed literature, and provides free access to the Ingenuity gene and biological pathway database.
Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that Sigma Life Science, its innovative biological products and services business, has signed an agreement with the Culture Collections of Public Health England, curators for the European Collection of Cell Cultures (ECACC®). In the agreement, the ECACC collection of unique, expertly preserved, authenticated human and animal cell cultures will be offered through the powerful Sigma-Aldrich website www.sigma.com/ecacc.
Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, today announced its Aldrich Materials Science initiative led the signing of a global marketing and distribution agreement with Applied Minerals, Inc. (OTCQB: AMNL) (OTC.BB: AMNL), the leading global producer of Dragonite™ Halloysite Clay. Dragonite™ Halloysite Clay is a natural ingredient whose characteristics can enhance product formulation, and is used in the development of plastics, flame retardant materials, environmental remediation products, paints and coatings, agriculture and other applications. Through the agreement, Dragonite™ Halloysite Clay is available to researchers, material scientists and engineers through Sigma-Aldrich and can be ordered at www.sigmaaldrich.com/matsci.
Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that BioReliance® (www.bioreliance.com), the biologics and early development services business under SAFC® (www.safcglobal.com), has signed an agreement to acquire the colonies required for the Big Blue® transgenic rodent mutation (TRM) assay and to obtain a license to its associated trademark from Agilent Technologies.
Read More

